Associations with fracture in patients with diabetes: a nested case-control study
Jakob Starup-Linde1, Søren Gregersen2, Peter Vestergaard3
1Department of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital THG, Aarhus, Denmark Clinical Institute, Aalborg University, Aalborg, Denmark.
BMJ Open
|February 14, 2016
Summary
This study found that certain factors like age, diabetes duration, and antiepileptic drug use increase fracture risk in diabetes patients. Optimal low-density lipoprotein cholesterol levels may reduce fracture risk.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Bone Health
Background:
- Diabetes mellitus is linked to a higher risk of fractures.
- This increased risk is not fully explained by bone mineral density or common risk factors.
- Identifying specific predictors of fracture in diabetes is crucial for prevention.
Purpose of the Study:
- To investigate the association of medication and biochemical markers with fracture risk in diabetes patients.
- To identify modifiable and non-modifiable risk factors for fractures in this population.
Main Methods:
- A nested case-control study design was employed.
- Data were sourced from the Danish National Hospital Discharge Registry, including 24,349 diabetes patients with fractures (cases) and 132,349 without (controls).
- Analysis included patient characteristics, comorbidities, biochemical parameters, and drug usage.
Main Results:
- Increased fracture odds were associated with age, diabetes duration, prior fracture diagnosis, alcohol-related diagnoses, and antiepileptic drug use.
- Higher total cholesterol levels also increased fracture odds.
- Low-density lipoprotein cholesterol levels showed a protective effect, with levels between 3.04-5.96 mmol/L being optimal.
Conclusions:
- Low-density lipoprotein cholesterol levels are a significant factor in understanding fracture risk in diabetes.
- These findings suggest that low-density lipoprotein cholesterol could be incorporated into existing fracture risk assessment models for diabetes patients.
- Further research into biochemical markers and medication effects can refine fracture prediction in diabetes.
Keywords:
DIABETES & ENDOCRINOLOGYRelated Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
630
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
630
Fractures: Bone Repair
6.5K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
6.5K
Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Pathophysiology of Diabetes
4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Chronic Kidney Disease II: Clinical Manifestations
927
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Bone Disorders
7.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.1K


